Aquestive Therapeutics Inc (NASDAQ:AQST) currently has a daily average trading volume of 2.75M but it saw 2083398 shares traded in last market. With a market cap of 302.75M USD, the company’s current market price of $3.37 came rising about 0.15 while comparing to the previous closing price of $3.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.23 and as low as $1.25.
Taking a look at 20-day trading activity of Aquestive Therapeutics Inc (AQST) gives us an average price of $3.99, while its current price level is -45.99% below from 52-week high level whereas it is 168.90% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.19 while that of 200 days or SMA-200 reads an average of $2.49. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.69% during that period while stretching the period over a month that decreases to 9.28%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 37.65 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Sandler which initiated the stock as “Overweight” in its note to investors issued on April 11, 2024, recommending a price target of $10 for it. RBC Capital Mkts issued its recommendations for the stock as it resumed the price target for the stock is $7.
Over the week, AQST’s stock price is moving -13.72% down while it is -18.72% when we observe its performance for the past one month. Year-to-date it is 66.58% up and over the past year, the stock is showing an upside performance of 142.09%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 0.11 beat the consensus estimate of -0.19 for the same. In next quarter, company is expected to be making quarterly sales of $12.6M as analysts are expecting the sales for current fiscal year at $50.21M and seeing the company making $57.98M in sales next year. Moreover, analysts are in estimates of $12.26M for current-quarter revenue.
Currently, Aquestive Therapeutics Inc’s total number of outstanding shares is 89.97M. Stock’s beta reads 2.94. Stock has a price to sale or P/S ratio amounts to 5.99. Its return on asset (ROA) is -13.75% on average.
